Oral transmucosal delivery of protein and peptide therapeutics

Drug Delivery to the Oral Cavity: Molecules to Market

Volumn , Issue , 2005, Pages 89-110

  Jasti, Bhaskara R ^a   Abraham, William ^b  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b MONSANTO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898645526     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Harris D and Robinson JR. Drug delivery via the mucus membranes of the oral cavity. J Pharm Sci 1992; 81:1-10.
2. Merkle HP and Wolany GJM. Intraoral peptide absorption. In: Biological Barriers to Protein Delivery, Audus KL and Raub TJ, eds., Plenum, New York, 1993, pp. 131-160.
3. Merkle HP and Wolany G. Buccal delivery for peptide drugs. J Control Rel 1992; 21:155-164.
4. Hoogstraate J. Buccal Drug Delivery. Kinetics and Histology of Transport Enhancement in vitro and in vivo. Ph.D. Thesis. Leiden University, The Netherlands, 1995.
5. Squier CA. The permeability of keratinized and non-keratinized oral epithelium to horseradish peroxidase. J Ultrastruct Res 1973; 43:160-177.
6. Squier CA and Hall BK. The permeability of mammalian nonkeratinized oral epithelia to horseradish peroxidase applied in vivo and in vitro. Arch Oral Biol 1984; 29:45-50.
7. Squier CA and Hall BK. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J Invest Dermatol 1985; 84:176-179.
8. Hill MW and Squier CA. The permeability of rat palatal mucosa maintained in organ culture. J Anat 1979; 128:169-178.
9. Dowty ME, Knuth KE, Irons BK, and Robinson JR. Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm Res 1992; 9:1113-1122.
10. Squier CA and Hall BK. In vitro permeability of porcine oral mucosa after epithelial separation, stripping, and hydration. Arch Oral Biol 1985; 30:485-491.
11. Squier CA and Hill MW. Oral mucosa. In: Oral Histology, Development, Structure, and Function. A.R. Ten Cate, ed., C.V. Mosby, St. Louis, MO, 1989, p. 341.
12. de Vries ME, Bodde HE, Verhoef HC, et al. Localization of the permeability barrier inside porcine buccal mucosa: A combined in vitro study of drug permeability, electrical resistance and tissue morphology. Int J Pharm 1991; 76:25-35.
13. Lesch CA, Squier CA, Cruchley A, et al. The permability of human oral mucosa and skin to water. J Dental Res 1989; 68:1345-1349.
14. Siegel IA, Izutsu KT, and Watson E. Mechanism of non-electrolyte penetration across dog and rabbit oral mucosa in vitro. Arch Oral Biol 1981; 26:357-361.
15. Siegel IA. Permeability of the rat oral mucosa to organic solutes measured in vivo. Arch Oral Biol 1984; 29:13-16.
16. Squier CA and Lesch CA. Penetration pathways of different compounds through epidermis and oral epithelia. J Oral Pathol 1988; 17:512-516.
17. Dowty ME, Knuth KE, and Robinson JR. Enzyme characterization studies on the rate-limiting barrier in rabbit buccal mucosa. Int J Pharm 1992; 88:293-302.
18. Hoogstraate AJ, Bodde HE, Cullander C, and Junginger JE. Diffusion rates and transport pathways of FITC-labelled model compounds through buccal epithelium. Pharm Res 1994; 11:83-89.
19. Lavker RM. Membrane coating granules: The fate of discharged lamellae. J Ultrastruct Res 1976; 55:79-86.
20. Romanowski AW, Squier CA, and Lesch CA. Permeability of rodent junctional epithelium to exogenous protein. J Periodont Res 1989; 23:81.
21. Squier CA. Effect of enzyme digestion on the permeability barrier in keratinizing and non-keratinizing epithelia. Br J Dermatol 1984; 111:253-264.
22. Wertz PW and Squier CA. Cellular and molecular basis of barrier function in oral epithelium. Crit Rev Ther Drug Carrier Syst 1991; 8:237-269.
23. Ho NFH, Barsuhn CL, Burton PS, and Merkle HP. Routes of delivery: Case studies. (3) Mechanistic insights to buccal delivery of proteinaceous substances. Adv Drug Del Rev 1992; 8:197-236.
24. Aungst BJ and Rogers NJ. Comparison of the effect of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm 1989; 53:227-235.
25. Dodda-Kashi S and Lee VHL. Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: Similarities in rates and involvement of aminopeptidases. Life Sci 1986; 38:2019.
26. Garren KW and Repta AJ. Buccal drug absorption. I. Comparative levels of esterase and peptidase activities in rat and hamster buccal and intestinal homogenates. Int J Pharm 1988; 48:189-194.
27. Stratford RE and Lee VHL. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: Implications in peptide delivery. Int J Pharm 1986; 30:73-82.
28. Lee VHL and Yamamoto A. Penetration and enzymatic barriers to peptide and protein absorption. Adv Drug Del Rev 1990; 4:171-207.
29. Li C, Bhat PP, and Johnston TP. In vitro release and permeation of oxytocin from a mucoadhesive buccal patch. Pharm Dev Tech 1996; 1(4):357-364.
30. Garren KW, Topp EM, and Repta AJ. Buccal absorption. III. Simultaneous diffusion and metabolism of an aminopeptidase substrate in the hamster cheek pouch. Pharm Res 1989; 6:966.
31. Ho NFH. Biophysical kinetic modeling of buccal absorption. Adv Drug Del Rev 1993; 12:61-97.
32. Lee VHL. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J Control Rel 1990; 13:213-223.
33. Kaelble DD, Ed. Physical Chemistry of Adhesion. Wiley Interscience, New York, 1971.
34. Alur HH, Beal JD, Pather SI, Mitra AK, and Johnston TP. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J Pharm Sci 1999; 12:1313-1319.
35. Huntsberger JR. Surface energy, wetting and adhesion. J Adhesion 1981; 12:3-12.
36. Gurny R, Meyer JM, and Peppas NA. Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials 1984; 5:336-340.
37. Lehr CM, Bowstra JA, Schacht EH, and Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan, and some other natural polymers. Int J Pharm 1992; 78:43-48.
38. Chen JL and Cyr CY. Composition producing adhesion through hydration, In. Adhesion in Biological Systems, RS Manly, ed., Academic, New York, 1970, pp. 164-181.
39. Kammer HW. Adhesion between polymers. Acta Polymerica 1983; 34:112-118.
40. Bodde HE, de Vries ME, and Junginger HE. Mucoadhesive polymers for the buccal delivery of peptides. Structure-adhesiveness relationships. J Control Rel 1990; 13:225-231.
41. Lehr CM, Bouwstra JA, Bodde HE, and Junginger HE. A surface energy analysis of mucoadhesion: contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharm Res 1992; 9:70-75.
42. Park K and Robinson JR. Bioadhesive polymers as platforms for controlled drug delivery: method to study bioadhesion. Int J Pharm 1984; 19:107-127.
43. Gu JM, Robinson JR, and Leung SHS. Binding of acrylic polymers to mucins/epithelial surfaces, structure property relationships. CRC Crit Rev Ther Drug Carrier Syst 1988; 5(1):21-67.
44. Peppas NA and Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissue. J Control Rel 1985; 2:257-275.
45. Anders R and Merkle HP. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int J Pharm 1989; 49:231-240.
46. Merkle HP, Anders R, and Wermerskirchen A. Mucoadhesive buccal patches for peptide delivery. In: Bioadhesive Drug Delivery Systems, Lenaerts V and Gurny R, eds., CRC Press, Boca Raton, FL, 1990, pp. 105-136.
47. Ishida M, Machida Y, Nambu N, and Nagai T. New mucosal dosage form of insulin. Chem Pharm Bull 1981; 29:810-816.
48. Aungst BJ and Rogers NJ. Site-dependence of absorption promoting actions of Laureth-9, Na-salicylate, Na2-EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res 1988; 5:305-308.
49. Aungst BJ, Rogers NJ, and Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J Pharmacol Exp Ther 1988; 244:23-27.
50. Morimoto K, Iwamoto T, and Morisaka K. Possible mechanisms for the enhancement of rectal absorption of hydrophilic drugs and polypeptides by aqueous polyacrylic acid gel. J Pharmacobio-Dyn 1987; 10:85-91.
51. Hori R, Komada F, and Okumura K. Pharmaceutical approach to subcutaneous dosage forms of insulin. J Pharm Sci 1983; 72:435-439.
52. Oh CK and Ritschel WA. Absorption characteristics of insulin through the buccal mucosa. Methods Find Exp Clin Pharmacol 1990; 12:275-279.
53. Oh CK and Ritschel WA. Biopharmaceutic aspects of buccal absorption of insulin. Methods Find Exp Clin Pharmacol 1990; 12:205-212.
54. Ritschel WA, Ritschel GB, Forusz A, and Kraeling M. Buccal absorption of insulin in the dog. Res Commun Chem Pathol Pharmacol 1989; 63:53-67.
55. Aungst BJ. Site-dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoter for insulin. Int J Pharm 1994; 105:219-225.
56. Hovgaard L, Mack EJ, and Kim SW. Insulin stabilization and G.I. Absorption. J Control Rel 1992; 19:99-108.
57. Al-Achi A, Greenwood R, and Walker B. Buccal administration of erythrocyteghosts- insulin in rats. J Control Rel 1994; 28:267-268.
58. Al-Achi A and Greenwood R. Buccal administration of human insulin in Streptozotocin- diabetic rats. Res Commun Chem Pathol Pharm 1993; 82:297-306.
59. Merkle HP and Wolany G. Buccal delivery for peptide drugs. J Control Rel 1992; 21:155-164.
60. Schurr W, Knoll B, Ziegler R, Anders R, and Merkle HP. Comparative study of intravenous, nasal, oral, and buccal TRH administration among healthy subjects. J Endocrinol Invest 1985; 8:41-44.
61. Small D. The Physical Chemistry of Lipids. Plenum, New York, 1986, p.93.
62. Ho NFH and Higuchi WI. Quantitative interpretation of in vivo buccal absorption of n-alkanoic acids by the physical model approach. J Pharm Sci 1971; 69:537-541.
63. Conradi RA, Hilger AR, Ho NFH, and Burton PS. The influence of peptide structure on transport across Caco-2 cells. Pharm Res 1991; 8:1453-1460.
64. Merkle HP, Anders R, Wermerskierchen A, et al. Buccal route of peptide and protein drug delivery. In: Peptide and Protein Drug Delivery, VHL Lee, ed., Marcel Dekker, New York, 1990, pp. 545-578.
65. Vyas K, Kellaway IW, Hanu AC, and Dennis A. The effects of some penetration enhancers on the in vitro diffusion of TRH across porcine buccal mucosa. Eur. J Pharm Sci 1994; 2:161.
66. Cassidy JP, Landzert NM, and Quadros E. Controlled buccal delivery of buprenorphine. J Control Rel 1993; 25:21-29.
67. Lee Y and Chien YW. Oral mucosa controlled delivery of LHRH by bilayer mucoadhesive polymer systems. J Control Rel 1995; 37:251-261.
68. Heiber SJ, Ebert CD, Dave SC, Smith K, Kim SW, and Mix D. In-vivo buccal delivery of calcitonin. J Control Rel 1994; 28:269-271.
69. Nakada Y, Awata N, Nakamichi C, and Sugimoto I. The effect of additives in the oral mucosal absorption of human calcitonin in rats. J Pharmacobio-Dyn 1988; 11:395-401.
70. Quadros E, Cassidy J, Gniecko K, and LeRoy S. Buccal and colonic absorption of CGS 16617, a novel ACE inhibitor. J Control Rel 1991; 19:77-86.
71. Mehta AC. Buccal and oral drugs: Induction of labour. Acta Chirurgica Hungarica 1986; 27:157-163.
72. Muller K and Osler M. Induction of labour. A comparison of intravenous, intranasal, and transbuccal oxytocin. Acta Obstet Gynecol Scand (Suppl) 1967; 9:59-62.
73. Poulsen EF. The induction and stimulation of labour with buccal desamino oxytocin and oxytocin tablets. Acta Obstet Gynecol Scand 1973; 52:303-305.
74. de Vries ME, Bodde HE, Verhoef JC, and Junginger HE. Transport of the peptide desglycinamide-arginine-vasopressin across buccal mucosa. J Control Rel 1990; 13:316.
75. Harris D and Robinson JR. Bioadhesive polymers in peptide drug delivery. Biomaterials 1990; 11:652-658.
76. Zhang J, Niu S, Ebert C, and Stanley TH. An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage. Int J Pharm 1994; 101:15-22.